Title Page Section: THROMBOSIS AND HEMOSTASIS Title: Cartilage Oligomeric Matrix Protein is a Natural Inhibitor of Thrombin

نویسندگان

  • Ying Liang
  • Yi Fu
  • Ruomei Qi
  • Meili Wang
  • Nan Yang
  • Li He
  • Fang Yu
  • Jian Zhang
  • Cai-Hong Yun
  • Xian Wang
  • Junling Liu
  • Wei Kong
چکیده

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University; Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, P. R. China; The Key Laboratory of Geriatrics, Beijing Hospital and Beijing Institute of Geriatrics, Ministry of Health, Beijing, P. R. China; Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China; Department of Biophysics, School of Basic Medical Sciences, Peking University, Beijing, P. R. China; and Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai, P. R. China.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cartilage oligomeric matrix protein is a natural inhibitor of thrombin.

Thrombin is an effector enzyme for hemostasis and thrombosis; however, endogenous regulators of thrombin remain elusive. Cartilage oligomeric matrix protein (COMP), a matricellular protein also known as thrombospondin-5, is essential for maintaining vascular homeostasis. Here, we asked whether COMP is involved in the process of blood coagulation. COMP deficiency shortened tail-bleeding and clot...

متن کامل

Rituximab for Treatment of Hemophilia A with High-Responder Inhibitors

Background: The development of inhibitors is a complication factor replacement therapy in hereditary factor VIII deficiency. Several management options are available for the treatment of inhibitor. Rituximab, a monoclonal antibody against CD20, reduces inhibitor level in rare bleeding disorders. The aim of this study was to evaluate the effectiveness of rituximab in lowering or eliminating the ...

متن کامل

A(nother) test meant to fill the gap between in vivo and ex vivo hemostasis.

Clot formation and dissolution in vivo can be considered as a highly integrated cellular/humoral process that acts through 3 interrelated pathways: primary hemostasis, coagulation, and fibrinolysis. Primary hemostasis is defined as the platelet–vessel wall interaction at the site of vascular injury that initiates when flowing platelets recognize (through their receptors) and bind (through the a...

متن کامل

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Active tissue factor pathway inhibitor is expressed on the surface of coated platelets

The incorporation of blood-borne forms of tissue factor (TF) into a growing blood clot is necessary for normal fibrin generation and stabilization of the blood clot. Tissue factor pathway inhibitor (TFPI) is the primary physiologic inhibitor of tissue factor and is present within platelets. Expression of TFPI on the platelet surface may be the optimal location for it to abrogate blood-borne TF ...

متن کامل

Lessons from ximelagatran: issues for future studies evaluating new oral direct thrombin inhibitors for venous thromboembolism prophylaxis in orthopedic surgery.

Venous thromboembolism is a frequent complication of total hip and knee replacement requiring prophylaxis with anticoagulants. A direct thrombin inhibitor-ximelagatran-did not show advantages over other anticoagulants and it was withdrawn from the market; however, new drugs are being developed. We conducted a systematic review and meta-analysis to identify conditions under which ximelagatran mi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2015